Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.64 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.64 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.64 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.50 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.50 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.45 |
| ▸ | CES1 | P23141 | 3/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | CES2 | O00748 | 2/20 | 0.44 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL693428 | 1.00 | HSD17B10 (0.64) | HSD17B10CYP1A2CYP2D6SMN1; SMN2KDM4E | |
| SCHEMBL8250205 | 0.83 | CYP1A2 (0.55) | HSD17B10CYP1A2CYP2D6SMN1; SMN2KDM4E | |
| SCHEMBL5998675 | 0.83 | L3MBTL1 (0.48) | HSD17B10CYP1A2CYP2D6SMN1; SMN2KDM4E | |
| SCHEMBL17003212 | 0.81 | PRSS1 (0.44) | HSD17B10CYP1A2CYP2D6SMN1; SMN2KDM4E | |
| SCHEMBL6301356 | 0.79 | CYP1A2 (0.47) | HSD17B10CYP1A2CYP2D6SMN1; SMN2MAPT | |
| SCHEMBL2331407 | 0.78 | NR4A2 (0.52) | HSD17B10CYP1A2CYP2D6SMN1; SMN2KDM4E | |
| SCHEMBL17489043 | 0.78 | CYP1A2 (1.00) | HSD17B10CYP1A2CYP2D6SMN1; SMN2KDM4E | |
| SCHEMBL14286180 | 0.78 | CYP1A2 (1.00) | HSD17B10CYP1A2CYP2D6SMN1; SMN2KDM4E | |
| SCHEMBL478673 | 0.78 | TSHR (0.48) | HSD17B10CYP1A2CYP2D6SMN1; SMN2KDM4E | |
| SCHEMBL13398132 | 0.78 | CYP1A2 (0.42) | HSD17B10CYP1A2CYP2D6SMN1; SMN2KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10344042-B2 | Production method for 2-fluoro-4-borono-L-phenylalanine, and precursor of 2-fluoro-4-borono-L-phenylalanine | STELLA PHARMA CORPORATION (JP) | 2019-07-09 | — | — | US | disclosed |
| US-10005794-B2 | Production method for 2-fluoro-4-borono-L-phenylalanine, and precursor of 2-fluoro-4-borono-L-phenylalanine | STELLA PHARMA CORPORATION (JP) | 2018-06-26 | — | — | US | disclosed |
| US-9815855-B2 | Method for producing 4-borono-L-phenylalanine having 18F atom introduced thereinto, and precursor of 4-borono-L-phenylalanine having 18F atom introduced thereinto | STELLA PHARMA CORPORATION (JP) | 2017-11-14 | — | — | US | disclosed |
| US-20170283441-A1 | PRODUCTION METHOD FOR 2-FLUORO-4-BORONO-L-PHENYLALANINE, AND PRECURSOR OF 2-FLUORO-4-BORONO-L-PHENYLALANINE | STELLA PHARMA CORPORATION (JP) | 2017-10-05 | — | — | US | disclosed |
| US-20170015684-A1 | METHOD FOR PRODUCING 4-BORONO-L-PHENYLALANINE HAVING 18F ATOM INTRODUCED THEREINTO, AND PRECURSOR OF 4-BORONO-L-PHENYLALANINE HAVING 18F ATOM INTRODUCED THEREINTO | STELLA PHARMA CORPORATION (JP) | 2017-01-19 | — | — | US | disclosed |
| EP-3112340-A1 | METHOD FOR PRODUCING 4-BORONO-L-PHENYLALANINE HAVING 18F ATOM INTRODUCED THEREINTO, AND PRECURSOR OF 4-BORONO-L-PHENYLALANINE HAVING 18F ATOM INTRODUCED THEREINTO | Stella Pharma Corporation (JP) | 2017-01-04 | — | — | EP | disclosed |
| US-20160311836-A1 | PRODUCTION METHOD FOR 2-FLUORO-4-BORONO-L-PHENYLALANINE, AND PRECURSOR OF 2-FLUORO-4-BORONO-L-PHENYLALANINE | STELLA PHARMA CORPORATION (JP) | 2016-10-27 | — | — | US | disclosed |
| EP-3085687-A1 | PRODUCTION METHOD FOR 2-FLUORO-4-BORONO-L-PHENYLALANINE, AND PRECURSOR OF 2-FLUORO-4-BORONO-L-PHENYLALANINE | Stella Pharma Corporation (JP) | 2016-10-26 | — | — | EP | disclosed |
| US-9409926-B2 | Chiral 4-boronophenylalanine (BPA) derivative and method for producing same, and method for producing 18F-labeled BPA using said derivative | STELLA PHARMA CORPORATION; OSAKA PREFECTURE UNIVERSITY PUBLIC CORPORATION (JP) | 2016-08-09 | — | — | US | disclosed |
| US-20150329564-A1 | CHIRAL 4-BORONOPHENYLALANINE (BPA) DERIVATIVE AND METHOD FOR PRODUCING SAME, AND METHOD FOR PRODUCING 18F-LABELED BPA USING SAID DERIVATIVE | OSAKA PREFECTURE UNIVERSITY PUBLIC CORPORATION (JP) | 2015-11-19 | — | — | US | disclosed |
| EP-2907818-A1 | CHIRAL 4-BORONOPHENYLALANINE (BPA) DERIVATIVE AND METHOD FOR PRODUCING SAME, AND METHOD FOR PRODUCING 18F-LABELED BPA USING SAID DERIVATIVE | Stella Pharma Corporation (JP) | 2015-08-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170015684-A1 | METHOD FOR PRODUCING 4-BORONO-L-PHENYLALANINE HAVING 18F ATOM INTRODUCED THEREINTO, AND PRECURSOR OF 4-BORONO-L-PHENYLALANINE HAVING 18F ATOM INTRODUCED THEREINTO | KISS1R, TH, DAO | HSD17B10 2954/4885CYP1A2 1418/4885CYP2D6 531/4885 |
| US-10005794-B2 | Production method for 2-fluoro-4-borono-L-phenylalanine, and precursor of 2-fluoro-4-borono-L-phenylalanine | NPR1, NPFFR2, NPFFR1 | HSD17B10 419/4885CYP1A2 442/4885CYP2D6 467/4885 |
| US-20170283441-A1 | PRODUCTION METHOD FOR 2-FLUORO-4-BORONO-L-PHENYLALANINE, AND PRECURSOR OF 2-FLUORO-4-BORONO-L-PHENYLALANINE | NPFFR2, NPR1, NPFFR1 | HSD17B10 758/4885CYP1A2 809/4885CYP2D6 908/4885 |
| US-10344042-B2 | Production method for 2-fluoro-4-borono-L-phenylalanine, and precursor of 2-fluoro-4-borono-L-phenylalanine | NPFFR2, NPR1, NPFFR1 | HSD17B10 758/4885CYP1A2 809/4885CYP2D6 908/4885 |
| US-20160311836-A1 | PRODUCTION METHOD FOR 2-FLUORO-4-BORONO-L-PHENYLALANINE, AND PRECURSOR OF 2-FLUORO-4-BORONO-L-PHENYLALANINE | NPR1, NPFFR2, NPFFR1 | HSD17B10 419/4885CYP1A2 442/4885CYP2D6 467/4885 |
| US-20150329564-A1 | CHIRAL 4-BORONOPHENYLALANINE (BPA) DERIVATIVE AND METHOD FOR PRODUCING SAME, AND METHOD FOR PRODUCING 18F-LABELED BPA USING SAID DERIVATIVE | FFAR3, BRS3, FSHR | HSD17B10 411/4885CYP1A2 362/4885CYP2D6 577/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.